Primary Mediastinal Lymphoma: Clinical Trials

1 trial for Primary Mediastinal Lymphoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Active not recruiting 1

Follow Primary Mediastinal Lymphoma: new trials by email Literature Review of Primary Mediastinal Lymphoma trials Research Report on Primary Mediastinal Lymphoma

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Nivolumab 40 mg in Combination With Chemo-Immunotherapy for Newly Diagnosed Primary Mediastinal B-Cell Lymphoma
Cyclophosphamide, Doxorubicin Hydrochloride, Etoposide Phosphate - Primary Mediastinal Lymphoma
Phase 3Active not recruitingNational Research Center for Hematology, Russia602022-04-012026-10-08

Interventions

Cyclophosphamide (1)  ·  Doxorubicin (1)  ·  Filgrastim (1)  ·  Injections (1)  ·  Nivolumab (1)  ·  Prednisolone (1)  ·  Rituximab (1)  ·  Vincristine (1)  ·  etoposide phosphate (1)  ·  pegfilgrastim (1)

Sponsors

National Research Center for Hematology, Russia (1)

Countries

Russia (1)

Top investigators

Elena Parovichnikova, MD,PhD (1)